Brett Favre tells Congress he’s been diagnosed with Parkinson’s

Brett Favre tells Congress he’s been diagnosed with Parkinson’s


Former NFL quarterback Brett Favre testifies before the House Ways and Means Committee at the Longworth House Office Building on September 24, 2024 in Washington, DC. 

Kevin Dietsch | Getty Images

Former Green Bay Packers quarterback Brett Favre said he’s been diagnosed with Parkinson’s, a stunning disclosure made to Congress on Tuesday while testifying about his potential misuse of taxpayer money.

Favre, appearing before the House Ways and Means Committee, has been accused of improperly using political connections to redirect public money to his alma mater and his own pocket.

“Sadly, I also lost an investment in a company that I believed was developing a breakthrough concussion drug I thought would help others, and I’m sure you’ll understand why it’s too late for me because I’ve recently been diagnosed with Parkinson’s,” Favre told lawmakers.

“This is also a cause dear to my heart. Recently, the doctor, running the company pleaded guilty to taking (public) money for his own use.”

Parkinson’s is a brain disorder that causes unintended or uncontrollable movements.

Symptoms, such as shaking and difficulty with balance and coordination, gradually worsen over time and often progress to difficulty walking and talking.

Favre was in Washington on Tuesday to answer questions about how he came into money from the federal Temporary Assistance for Needy Families (TANF) program.

The Hall of Fame QB improperly received program money for speaking engagements that he never made, according to a state auditor.

Favre is also accused of using his ties for former Gov. Phil Bryant to lobby for TANF funds to go to a new volleyball facility at his alma mater, the University of Southern Mississippi, where his daughter was a player.

Favre has not been criminally charged, but he is repaying some of the money.



Source

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to  billion
Health

OpenEvidence, the ‘ChatGPT for doctors,’ doubles valuation to $12 billion

A startup widely known as “ChatGPT for doctors” raised a new funding round that values the company at $12 billion. OpenEvidence, based in Miami, Florida, closed a $250 million financing, led by Thrive Capital and DST, the company told CNBC. The startup first raised outside capital in February, when it reeled in $75 million from […]

Read More
Another alliance of health care and AI signals why pharma stocks should be back in favor
Health

Another alliance of health care and AI signals why pharma stocks should be back in favor

Bristol Myers Squibb and Microsoft ‘s new partnership aimed at accelerating early detection of lung cancer marks the latest way health care and artificial intelligence are rapidly intersecting. Bristol Myers said on Tuesday it will work with Microsoft’s AI-powered radiology platform to develop and launch imaging algorithms. These new tools, which can be used to […]

Read More
Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry
Health

Drug pricing, patent losses and deals: Here’s what pharma execs see ahead in the industry

US President Donald Trump arrives for an announcement in the Roosevelt Room of the White House in Washington, DC, US, on Friday, Dec. 19, 2025. Will Oliver | Bloomberg | Getty Images Drug pricing. Looming patent cliffs. Dealmaking. The first year of Trump 2.0. Those are among the themes that dominated conversations last week as drugmakers […]

Read More